EAGLE PHARMACEUTICALS, INC.【EGRX】

Market cap

$14.29K

P/E ratio

	Sep 30, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Cash and cash equivalents	23	79	53	115	79	110	103	98	55
Accounts receivable, net	7	26	42	54	66	48	51	41	72
Inventories	1	15	3	5	8	7	8	22	48
Prepaid expenses and other current assets	2	2	11	15	10	15	4	12	13
Total current assets	53	122	109	189	164	179	166	173	189
Property and equipment, net	0	2	3	7	2	2	2	2	1
Intangible assets, net	-	-	33	23	18	16	13	11	118
Goodwill	-	-	40	40	40	40	40	40	45
Deferred tax asset	-	-	29	11	14	14	15	19	27
Other assets	0	0	0	0	1	4	17	10	26
Total assets	53	125	214	270	239	255	253	254	406
Accounts payable	4	4	15	12	10	5	6	16	19
Accrued Liabilities, Current	10	24	25	15	24	28	24	32	86
Short-term debt	-	-	-	5	6	5	8	26	6
Total current liabilities	20	34	41	47	40	39	38	74	111
Other long-term liabilities	-	-	-	-	-	3	4	3	5
Long-term debt	-	-	-	43	38	34	25	-	56
Total liabilities	-	-	-	-	-	75	67	77	173
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	0	0	0	0	0	0	0	0	0
Additional paid in capital	137	197	214	234	256	279	305	326	366
Accumulated other comprehensive loss	-	-	-	-	-	-	-	-0	-1
Retained earnings	-104	-107	-26	26	58	73	84	76	112
Treasury stock, at cost, 4,552,730 and 4,111,622 shares as of December 31, 2022 and 2021, respectively	-	-	37	81	154	172	204	225	243
Total stockholders' equity	33	90	151	179	161	179	186	176	234
Total liabilities and stockholders' equity	53	125	214	270	239	255	253	254	406